1. Xue X, Gao Z, Zhu J, Xu Y, Li X. Clinical evaluation of chinese guidelines for community-acquired pneumonia. J Peking Univ Heal Sci. 2006;38:276–9.
2. Kyaw MH, Rose, Jr. CE, Fry AM, Singleton JA, Moore Z, Zell ER, et al. The Influence of Chronic Illnesses on the Incidence of Invasive Pneumococcal Disease in Adults. J Infect Dis. 2005;192:377–86.
3. Allard R, Leclerc P, Tremblay C, Tannenbaum TN. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care. 2010;33:1491–3.
4. Lu M, Yao W, Zhong N, Zhou Y, Wang C, Chen P, et al. Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China. Respirology. 2010;15:1072–8.
5. Hong KW, Cheong HJ, Choi WS, Lee J, Wie SH, Baek JH, et al. Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity and Mortality (HIMM) surveillance. J Infect Chemother. 2014;20:9–14.
6. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populations at risk for severe or complicated avian influenza H5N1: A systematic review and meta-analysis. PLoS One. 2014;9:1–15.
7. Barker WH, Mullooly JP. Influenza Vaccination of Elderly Persons: Reduction in Pneumonia and Influenza Hospitalizations and Deaths. JAMA J Am Med Assoc. 1980;244:2547–9.
8. Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine. 1999;17 SUPPL. 1:91–3.
9. Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease BT - Cochrane Database Syst Rev. 2006.
10. Looijmans-Van Den Akker I, Verheij TJM, Buskens E, Nichol KL, Rutten GEHM, Hak E. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care. 2006;29:1771–6.
11. Christenson B, Hedlund J, Lundbergh P, Örtqvist Å. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J. 2004;23:363–8.
12. Zhang YY, Tang XF, Du CH, Wang BB, Bi ZW, Dong BR. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis. Hum Vaccines Immunother. 2016;12:3056–64. doi:10.1080/21645515.2016.1221552.
13. Chang YC, Chou YJ, Liu JY, Yeh TF, Huang N. Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan - A representative population-based comparative study. J Infect. 2012;65:231–8. doi:10.1016/j.jinf.2012.04.014.
14. Kenneth J Smith, MD, MS, Bruce Y. Lee, MD, MBA, Mary Patricia Nowalk, PhD, RD M, Raymund, PhD and RKZ. Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds. NIH Public Access. 2010;5:379–90.
15. World Health Organization. 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec. 2008;83:373–84. https://www.who.int/wer/2008/wer8342.pdf?ua=1.
16. World Health Organization. Influenza ( Seasonal ). 2019; November 2018:1–7. https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal). Accessed 24 Apr 2019.
17. Advisory Committee on Immunization Practices. Recommended Adult Immunization Schedule for ages 19 years or older. 2019;:6. www.cdc.gov/vaccines/pubs/surv-manual.
18. Qin Y, Yu HJ, Chinese Prevention Medicine Association. Technical guideline on application of pneumococcal vaccine in China (2012). Chinese J Epidemiol. 2012;33:1101–10. http://www.ncbi.nlm.nih.gov/pubmed/23290891.
19. L. F, P. Y, T. Z, J. Y, C. F, Y. Q, et al. Technical guidelines for the application of seasonal influenza vaccine in China (2014–2015). Hum Vaccines Immunother. 2015;11:2077–101. doi:10.1080/21645515.2015.1027470.
20. American Diabetes Association. Executive summary: Standards of medical care in diabetes--2013. Diabetes Care. 2013;36 Suppl 1.
21. Alvar A, Decramer M, Frith P. Global Initiative for Chronic Obstructive Lung Disease. Pocket guide to COPD diagnosis, management and prevention. Global initiative for chronic obstructive lung disease. 2017;1–42. doi:10.1097/00008483-200207000-00004.
22. Yang J, Atkins KE, Feng L, Pang M, Zheng Y, Liu X, et al. Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis. Vaccine. 2016;34:5724–35. doi:10.1016/j.vaccine.2016.10.013.
23. Shanghai Municipal Center for Disease Control and Prevention. Report on Chronic and Non-communicable Disease Surveillance in Shanghai, 2013. Shanghai Science Popularization Publishing House; 2014.
24. Wagner AL, Montgomery JP, Xu W, Boulton ML. Influenza vaccination of adults with and without high-risk health conditions in China. J Public Heal (United Kingdom). 2017;39:358–65.
25. World Health Organization. Vaccines against influenza WHo position paper – November 2012. Wkly Epidemiol Rec. 2012;87:461–76. https://www.who.int/wer/2012/wer8747.pdf?ua=1.
26. American Diabetes Association. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2018. Diabetes Care. 2018;41 Suppl 1:S73–85. doi:10.2337/dc18-S008.
27. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.
28. Chinese General Administration of Quality Supervision Inspection and Quarantine. Classification and codes of occupations. 2009.
29. Xiaodong S, Xiang G. Knowledge and Attitude toward Pneumonia and Pneumococcal Polysaccharide Vaccine among the Elderly in Shanghai, China: A Crosssectional Questionnaire Survey. J Pulm Respir Med. 2016;06.
30. Ye C, Zhu W, Yu J, Li Z, Hu W, Hao L, et al. Low coverage rate and awareness of influenza vaccine among older people in Shanghai, China: A cross-sectional study. Hum Vaccines Immunother. 2018;14:2715–21. doi:10.1080/21645515.2018.1491246.
31. Yuan X. China’s vaccine production scare. Lancet (London, England). 2018;392:371. doi:10.1016/S0140-6736(18)31725-2.
32. Murphy F. China vaccine scandal: investigations begin into faulty rabies and DTaP shots. BMJ. 2018;362 July:k3244. doi:10.1136/bmj.k3244.
33. Centers for Disease Control and Prevention. Vaccination Coverage Among Adults in the United States, National Health Interview Survey, 2016. 2016. https://www.cdc.gov/vaccines/imz-managers/coverage/adultvaxview/pubs-resources/NHIS-2016.html. Accessed 25 Apr 2019.
34. Domínguez A, Soldevila N, Toledo D, Godoy P, Torner N, Force L, et al. Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study. Hum Vaccines Immunother. 2016;12:1891–9. doi:10.1080/21645515.2016.1149661.
35. Siu JY. Perceptions of Seasonal Influenza and Pneumococcal Vaccines Among Older Chinese Adults. Gerontologist. 2018;XX Xx:1–10.
36. Hong Kong Information Services Department. Vaccination programmes. 2019;4–6. https://www.chp.gov.hk/tc/features/18881.html. Accessed 27 Apr 2019.
37. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect. 2009;58:446–58. doi:10.1016/j.jinf.2009.04.001.
38. Cha SH, Paik JH, Lee MR, Yang H, Park SG, Jeon YJ, et al. Influenza vaccination coverage rate according to the pulmonary function of Korean adults aged 40 years and over: Analysis of the Fifth Korean National Health and Nutrition Examination Survey. J Korean Med Sci. 2016;31:709–14.
39. Keung Wong DF, Li CY, Song HX. Rural migrant workers in urban China: Living a marginalised life. Int J Soc Welf. 2007;16:32–40.
40. Fang R, Lv M, Wu J, Pang X, Deng Y, Lei T, et al. The free vaccination policy of influenza in Beijing, China: The vaccine coverage and its associated factors. Vaccine. 2016;34:2135–40. doi:10.1016/j.vaccine.2016.02.032.
41. Baer R, Weller S, Pachter L, et al. Cross-Cultural Perspectives on the Common Cold: Data from Five Populations. Hum Organ. 1999;58(3):251-260.
42. Andrews RM, Skull SA, Byrnes GB, Campbell DA, Turner JL, McIntyre PB, et al. Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria. Commun Dis Intell Q Rep. 2005;29:283–8. http://www.ncbi.nlm.nih.gov/pubmed/16220865.